(Q33721096)

28 July 2017

1 reference

title

Contribution of randomised controlled trials to understanding and management of early breast cancer (English)

1 reference

28 July 2017

M Baum

1

1 reference

PubMed ID

10463904

28 July 2017

J Houghton

series ordinal

2

1 reference

PubMed ID

10463904

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

319

1 reference

28 July 2017

7209

1 reference

28 July 2017

568-571

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Role of radiotherapy following total mastectomy in patients with early breast cancer. The Closed Trials Working Party of the CRC Breast Cancer Trials Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Results of the Cancer Research Campaign Adjuvant Trial for Perioperative Cyclophosphamide and Long-Term Tamoxifen in Early Breast Cancer reported at the tenth year of follow-up. Cancer Research Campaign Breast Cancer Trials Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Comparison of radical mastectomy with alternative treatments for primary breast cancer:A first report of results from a prospective randomized clinical trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1116442

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

30 October 2018

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Neoadjuvant chemotherapy in operable breast cancer

1 reference

12 December 2020

Adjuvant CMF chemotherapy in operable breast cancer: ten years later

1 reference

12 December 2020

Tamoxifen and contralateral breast cancer

1 reference

12 December 2020

On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases

1 reference

12 December 2020

Treatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial

1 reference

12 December 2020

The role of prophylactic castration in the therapy of human mammary cancer

1 reference

12 December 2020

Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted Triphenylethylenes

1 reference

12 December 2020

Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party

1 reference

12 December 2020

Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome

1 reference

12 December 2020

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials

1 reference

12 December 2020

Sudden fall in breast cancer death rates in England and Wales

1 reference

12 December 2020

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

12 December 2020

Work on your theories!

1 reference

12 December 2020

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

12 December 2020

Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast Cancer

1 reference

12 December 2020

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

12 December 2020

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.319.7209.568

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

10463904